Certificate under Reg 74(5) of SEBI (DP) Regulation for the quarter ended on June, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has submitted a certificate to BSE as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations for the quarter ended June 2025. This is a routine compliance filing confirming that share certificates received from depository participants for dematerialization during the quarter have been properly processed and reconciled. Such certificates are typically submitted by the company's Registrar and Share Transfer Agent on a quarterly basis. The filing does not contain any operational or financial information about the company.
This is a standard procedural compliance filing and has no direct impact on shareholders, business operations, or the stock price. It only confirms that the company's share dematerialization activities are in order.